Bryan Y.

Bryan Y. has extensive work experience in the biopharmaceutical industry. Bryan is currently serving as the VP, US CMC Head at I-Mab Biopharma. Before joining I-Mab Biopharma, they worked as the Director, Head of Regulatory CMC at Zymeworks Biopharmaceuticals Inc. from 2020 to 2021.

Prior to their role at Zymeworks, Bryan worked at Amgen for several years. Bryan held the positions of Assoc Director/Sr. Manager, Regulatory CMC and Device from 2015 to 2020, and Principal Engineer, Drug Product and Delivery Device from 2004 to 2015.

Bryan started their career at Eli Lilly and Company as an Analytical Chemist in the Bioprocess and Pharmaceutical Development department. Bryan worked at Eli Lilly from 1998 to 2004.

Overall, Bryan Y. has gained diverse expertise and knowledge in regulatory CMC, drug development, and device engineering throughout their career in the biopharmaceutical industry.

Bryan Y. has attended Purdue University, Oregon State University, and the University of Southern California. However, no specific degree or field of study information is provided.